SLU-PP-332 capsuleyog ib qho tshuaj tshiab tshiab nrog cov tseem ceeb ntawm cov tshuaj estrogen receptor-related receptor (ERR) agonist. Nws qhib peb lub subtypes ntawm ERR (ERR , ERR , thiab ERR ) kom simulate cov teebmeem physiological coj los ntawm kev tawm dag zog, ua kom cov mitochondrial muaj nuj nqi thiab cellular respiration ntawm skeletal leeg, txhawb fatty acid oxidation, txo cov rog, thiab txhim kho kev ua kom muaj zog. Cov kev tshawb fawb tau pom tias cov tshuaj no tuaj yeem txhim kho cov cim qhia txog cov kab mob metabolic, xws li txo cov ntshav lipids, txhim kho cov piam thaj hauv siab thiab rog rog, thiab tshwj xeeb tshaj yog rau cov neeg uas tsis tuaj yeem tawm dag zog txaus vim hnub nyoog, kab mob lossis kev txwv lub cev. Nws muab lub tswv yim tshiab rau kev kho mob ntawm cov kab mob metabolic thiab kev tswj hwm qhov hnyav. Tsis ntev los no, kev hloov pauv hauv kev xaiv cov khoom lag luam los ntawm ib lub sijhawm ntev - tus khub los ntawm Brazil tau muab cov ntaub ntawv zoo heev rau kev soj ntsuam cov qauv kev txhim kho ntawm kev npaj tshuaj. Tus neeg siv khoom tau npaj los yuav SLU-PP-332 txhaj tshuaj formulation, tab sis tom qab kawm txog kev sib tw solubility ntawm cov khoom muaj nyob rau hauv aqueous systems, lawv thiaj li tig mus rau cov tshuaj ntsiav tshuaj kho mob - thiab qhov kev xaiv no coincided raws nraim nrog kev txiav txim siab ntawm cov neeg siv khoom thoob ntiaj teb feem ntau.
|
|
|
|
|
|
|
|
Qhov teeb meem tawg: Vim li cas cov tshuaj txhaj tshuaj tsis yog qhov kev xaiv zoo tshaj plaws rau SLU-PP-332?
SLU-PP-332, raws li cov khoom xyaw nquag nrog cov nqi kho mob tshwj xeeb, muaj kev txwv tsis pub muaj nyob hauv nws cov solubility thiab kev ruaj ntseg hauv cov tshuaj aqueous vim nws cov khoom siv physicochemical. Qhov teeb meem no tsis yog ib qho kev sib cais tab sis ib qho kev sib tw hauv kev tsim tshuaj niaj hnub no.
Kev tshawb fawb
Cov yam ntxwv ntawm cov qauv molecular
Lub molecule ntawm SLU-PP-332 tej zaum yuav muaj hydrophobicity siab los yog ib tug tshwj xeeb siv lead ua qauv, uas ua rau nws solubility nyob rau hauv dej tsis ncav cuag lub concentration ntau yam uas yuav tsum tau rau txhaj tshuaj. Kev mob siab ua kom lub cosolvent lossis hloov pauv tus nqi pH yuav cuam tshuam rau kev ruaj ntseg lossis kev nyab xeeb ntawm cov tshuaj.
Kev xav txog kev ruaj ntseg
Qee cov khoom xyaw nquag muaj feem xyuam rau hydrolysis, oxidation lossis photolysis hauv aqueous daws, tshwj xeeb tshaj yog thaum khaws cia. Cov khoom txhaj tshuaj muaj cov kev cai nruj heev rau kev tsis muaj menyuam thiab kev ruaj ntseg. Ib qho kev nce hauv cov khoom degradation tuaj yeem ua rau muaj kev pheej hmoo tsis txaus ntseeg.
Bioavailability cuab
Solubility tsis zoo tsis tsuas yog cuam tshuam rau kev npaj ntawm formulation, tab sis kuj yuav cuam tshuam rau kev nqus thiab faib cov tshuaj hauv lub cev. Txawm hais tias injectables bypass cov txheej txheem nqus, yog tias cov khoom xyaw nquag tuaj yeem ua rau los nag lossis sib sau ua ke hauv ib puag ncig physiological, nws tuaj yeem txo qhov kev kho mob.
Qhov xwm txheej tiag tiag ntawm cov neeg siv khoom Brazilian:
Cov huab cua ntub thiab kub hauv Brazil ua rau muaj kev xav tau ntau dua ntawm kev khaws cia thiab kev thauj mus los ntawm kev txhaj tshuaj. Thaum xub thawj, cov neeg siv khoom yuav tau xaiv cov tshuaj txhaj tshuaj raws li kev txiav txim siab ntawm kev ua tau zoo sai. Txawm li cas los xij, tom qab kawm txog cov teeb meem solubility, lawv tam sim ntawd pom tau tias qhov no yuav ua rau:
Nce nqi ntxiv rau kev tsim tshuaj
Yuav tsum muaj kev txhawb nqa txias chain logistics
Tau ntsib cov teeb meem loj dua hauv kev tswj kom zoo
Tej zaum cov neeg mob tsis yooj yim siv nws
Qhov zoo ntawm kev tshawb fawb ntawm cov tshuaj ntsiav tshuaj: Vim li cas lawv tau dhau los ua kev pom zoo hauv kev lag luam?
Thaum txoj kev txhaj tshuaj raug thaiv, cov tshuaj ntsiav tshuaj, nrog rau lawv cov txiaj ntsig kev tshawb fawb tshwj xeeb, ib txwm dhau los ua tus neeg nqa khoom zoo tshaj plaws rau SLU-PP-332. Qhov kev xaiv no tsis yog kev sib haum xeeb tab sis yog ib qho kev daws teeb meem zoo raws li kev ntsuas ntau yam.
Technical Advantage Matrix
| Dimension | Qhov zoo ntawm Capsule Formulation | Adaptability ntawm SLU-PP-332 |
| Kev tiv thaiv lub cev | Cais tawm ntawm lub teeb, oxygen thiab av noo | Tiv thaiv cov khoom xyaw nquag uas nkag siab rau cov dej noo thiab cua sov |
| Masking nyhuv | Ua tiav daim npog qhov tsis kaj siab | Haum rau cov tebchaw uas tej zaum yuav muaj qhov iab saj |
| Tswj tau tso tawm | Nws tuaj yeem tsim tau sai - tso tawm, qeeb - tso tawm lossis enteric-coated | Customized raws li cov cai ntawm pharmacokinetics |
| Formulation yooj | Fillable hmoov, granules, thiab micro- ntsiav tshuaj | daws qhov teeb meem ntawm solubility |
| Production adaptability | Cov txheej txheem yog tus paub tab thiab yooj yim rau scale | Txo cov kev pheej hmoo ntawm kev hloov technology |
Clinical zoo
Tus neeg mob ua raws
Kev tswj hwm qhov ncauj yog txoj kev siv tau zoo tshaj plaws, tshwj xeeb tshaj yog tsim nyog rau cov neeg mob uas muaj kab mob ntev uas yuav tsum tau kho ntev -.
Kev noj tshuaj raug
Niaj hnub nimno capsule filling tshuab tuaj yeem ua tiav qhov raug siab heev, kom ntseeg tau qhov sib xws ntawm cov khoom xyaw nquag hauv txhua lub tshuaj ntsiav.
Kev tswj hwm tshuaj sib xyaw ua ke tuaj yeem
Cov tshuaj ntsiav tuaj yeem muaj ob qho tib si sai sai - tso tawm thiab ruaj khov - tso tawm cov khoom, lossis ntau hom khoom xyaw, kom ua tiav txoj kev tso tawm nyuaj.
Qhov zoo ntawm SLU-PP-332 capsules
SLU-PP-332 capsule, raws li cov tshuaj estrogen-related receptor (ERR) agonist, muaj nws cov txiaj ntsig tseem ceeb hauv kev muab cov kev daws teeb meem tshiab rau kev kho cov kab mob metabolic thiab kev tswj hwm kev noj qab haus huv los ntawm kev ua raws li cov txiaj ntsig ntawm kev tawm dag zog. Cov txiaj ntsig tshwj xeeb yog raws li hauv qab no:
Ntau- phiaj xwm ua kom muaj zog, kev tswj hwm cov metabolism
SLU-PP-332 tuaj yeem ua rau tib lub sijhawm qhib peb lub receptor subtypes ntawm ERR , ERR thiab ERR , nrog rau kev sib raug zoo tshaj plaws rau ERR (EC50=98 nM). Qhov kev ua haujlwm ntau lub hom phiaj no ua rau nws nkag siab txog cov txheej txheem metabolic cuam tshuam nrog lub zog:
Txhawb nqa fatty acid oxidation
Los ntawm upregulating noob muaj feem xyuam rau fatty acid oxidation (FAO), txhim khu cov rog tawg rau lub zog mov thiab txo cov rog.
Txhim kho mitochondrial muaj nuj nqi
Ua kom cov ntsiab lus thiab oxidative muaj peev xwm ntawm mitochondria hauv cov leeg pob txha, txhim kho lub zog metabolism, zoo ib yam li cov txiaj ntsig ntawm kev cob qhia aerobic.
Tswj cov metabolism hauv qabzib
Ua kom cov leeg nce ntshav qabzib, txhim kho cov tshuaj insulin, thiab pab tswj cov ntshav qab zib.
Simulate cov txiaj ntsig ntawm kev tawm dag zog yam tsis muaj kev tawm dag zog tiag tiag
SLU-PP-332 activates ERR signaling pathway, inducing the body to undergo physiological adaptive change similar to kev tawm dag zog:
Txhim kho endurance
Hauv kev sim nas, ib txwm -cov nas hnyav uas tau coj SLU-PP-332 tau lawv lub sijhawm ua haujlwm txuas ntxiv los ntawm 70% thiab lawv qhov kev khiav deb tau nce 45%.
Kev siv hluav taws xob ntau ntxiv
So lub zog siv nyiaj ntau ntxiv, txhawb kev rog rog thiab txo cov rog rog.
Txhim kho metabolic noj qab haus huv
Tom qab ib hlis ntawm kev siv tshuaj, cov nas rog rog poob 12% ntawm lawv qhov hnyav, thiab lawv cov qib ntawm daim siab rog, cov roj cholesterol, thiab triglycerides poob qis, tsis muaj kev cuam tshuam rau kev noj qab haus huv lossis kev txaus siab txav mus los.
Dav siv tau thiab ua tau raws li cov kev xav tau sib txawv
Cov txheej txheem tshwj xeeb ntawm kev ua ntawm SLU-PP-332 ua rau nws muaj kev thov dav dav hauv ntau qhov chaw:
Kev kho mob ntawm metabolic syndrome
Los ntawm kev txo cov rog rog thiab txhim kho insulin rhiab heev, nws pab txo cov tsos mob cuam tshuam nrog metabolic syndrome.
01
Kev tswj kev rog rog
Muab kev kho mob tshiab rau cov tib neeg uas tsis tuaj yeem poob phaus los ntawm kev tawm dag zog, tshwj xeeb tshaj yog rau cov neeg uas tsis tuaj yeem tawm dag zog kom txaus vim muaj hnub nyoog, raug mob, lossis mob ntev.
02
Txhim kho cov leeg nqaij
Txhim kho pob txha pob txha oxidative muaj peev xwm thiab endurance, txo cov leeg nqaij thaum poob phaus, thiab tswj cov leeg nqaij thiab ua haujlwm.
03
Tiv thaiv hnub nyoog- kab mob ntsig txog
Hauv cov qauv ntawm lub raum laus, SLU-PP-332 tuaj yeem txhim kho mitochondrial muaj nuj nqi thiab inhibit inflammatory markers, tawm tswv yim nws muaj peev xwm siv nyob rau hauv kev tiv thaiv kev laus.
04
Kev soj ntsuam kev nyab xeeb ua ntej, nrog rau kev pheej hmoo tsawg ntawm kev phiv
Hauv kev tshawb fawb preclinical, SLU-PP-332 tsis tau pom muaj kev phiv loj heev, thiab tsis pom muaj qhov tshwm sim tsis zoo hauv cov qauv nas. Nws cov txheej txheem ntawm kev txiav txim yog qhov tseeb, los ntawm kev ua kom muaj ERR receptor los tswj cov txheej txheem metabolic, txo qhov kev pheej hmoo ntawm kev tawm - cov teebmeem. Txawm li cas los xij, kev ntsuam xyuas dav dav ntawm nws txoj kev nyab xeeb mus sij hawm ntev thiab cov kev mob tshwm sim tseem yuav tsum tau tshawb fawb ntxiv.
Muaj peev xwm zoo rau kev tsim kho kom zoo thiab txhim kho cov tshuaj yooj yim
Txawm hais tias kev tshawb fawb tam sim no ntawm SLU-PP-332 feem ntau yog tsom rau kev txhaj tshuaj, nws muaj peev xwm ua tshuaj rau qhov ncauj tau nyiam. Nyob rau hauv lub neej yav tom ntej, los ntawm kev txhim kho formulation, xws li kev loj hlob ntawm kev npaj ntawm qhov ncauj, qhov yooj yim ntawm kev siv tshuaj yuav ua tau zoo dua, ua tau raws li cov kev xav tau ntawm cov neeg mob rau kev kho mob mus ntev.